AgomAb Therapeutics N.V. American Depositary Shares Current Cash

As of the most recent data (December 2025), AGMB shows a current cash of $86M. That compares with $170M in the prior-year period — down 49.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AGMB's current cash is now $86M (was $170M) — a 49.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AgomAb Therapeutics N.V. American Depositary Shares is outperforming or lagging.

Tracking AGMB's current cash over time shows whether AgomAb Therapeutics N.V. American Depositary Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $86M That compares with $170M in the prior-year period — down 49.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has AgomAb Therapeutics N.V. American Depositary Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $86M) with ownership activity and broader fundamentals.

AgomAb Therapeutics N.V. American Depositary Shares's current cash is $86M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.